Invasive pulmonary aspergillosis in immunocompromized children: Diagnosis and classification;Aspergillose pulmonaire invasive chez les enfants immunodé primés: Méthodes diagnostiques et classification

Archives de Pediatrie

Volumn 10, Issue SUPPL. 5, 2003, Pages

  Tabone, Marie Dominique ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Aspergillosis; Child; Immunocompromised host

Indexed keywords

GALACTOMANNAN;

ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ASPERGILLUS; CHILD; CHRONIC GRANULOMATOUS DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONSTRUCTION WORK; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; LUNG ASPERGILLOSIS; LUNG LAVAGE; NEUTROPENIA; OPPORTUNISTIC INFECTION; POLYMERASE CHAIN REACTION; RISK FACTOR; THORAX RADIOGRAPHY; ASPERGILLOSIS; CLASSIFICATION; IMMUNOLOGY; LUNG MYCOSIS; PATHOPHYSIOLOGY; REVIEW;

ASPERGILLOSIS; CHILD; HUMANS; IMMUNOCOMPROMISED HOST; LUNG DISEASES, FUNGAL; RISK FACTORS;

EID: 0346847744     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(03)90630-0     Document Type: Conference Paper

References (28)

1. Walmsley S, Devi S, King S, Schneider R, Richardson S, Ford-Jones L. Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J 1993; 12: 673-82.
2. Davies SM, Wagner JE, Shu XO, Blazar BR, Katsanis E, Orchard PJ, et al. Unrelated donor bone marrow transplantation for children with acute leukemia. J Clin Oncol 1997; 15: 557-65.
3. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-66.
4. Abbasi S, Shenep JL, Hughes WT, Flynn PM. Aspergillosis in children with cancer: A 34-year experience. Clin Infect Dis 1999; 29: 1210-9.
5. Groll AH, Kurz M, Schneider W, Witt V, Schmidt H, Schneider M, et al. Five-year-survey ofinvasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses 1999; 42: 431-42.
6. Mouy R, Veber F, Blanche S, Donadieu J, Brauner R, Levron JC, et al. Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 1994; 125: 998-1003.
7. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Defective antifungal activity of monocyte-derived macrophages from human immunodeficiency virus-infected children against Aspergillus fumigatus. J Infect Dis 1993; 168: 1562-5.
8. Weinberger M, Elattar I, Marshall D, Steinberg SM, Redner RL, Young NS, et al. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) 1992; 71: 24-43.
9. O'Donnell MR, Schmidt GM, Tegtmeier BR, Faucett C, Fahey JL, Ito J, et al. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 1994; 12: 827-34.
10. Aisner J, Murillo J, Schimpff SC, Steere AC. Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med 1979; 90: 4-9.
11. Robertson MJ, Larson R. Reccurent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing courses of intensive chemotherapy. Am J Med 1988; 84: 233-9.
12. Barnes RA, Rogers TR. Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. J Hosp Infect 1989; 14: 89-94.
13. Anderson K, Morris G, Kennedy H, Croall J,Michie J, Richardson MD, et al. Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air. Thorax 1996; 51: 256-61.
14. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 1982; 69: 617-31.
15. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139-47.
16. Rogers TR, Haynes KA, Barnes RA. Value of antigen detection in predicting invasive aspergillosis. Lancet 1990; 336: 1210-3.
17. Sulahian A, Tabouret M, Ribaud P, Sarfati J, Gluckman E, Latge JP, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1996; 15: 139-45.
18. Bretagne S, Marmorat-Khuong A, Kuentz M, Latge JP, Bart-Delabesse E, Cordonnier C. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997; 35: 7-15.
19. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-10.
20. Rohrlich P, Sarfati J, Matriani P, Duval M, Carol A, Saint-Martin C, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996; 15: 232-7.
21. Tabone MD, Vu-Thien H, Latge JP, Landman-Parker J, Perez-Castiglioni P, Moissenet D, et al. Value of galactomannan detection by sandwich enzyme-linked immunosorbent assay in the early diagnosis and follow-up of invasive aspergillosis. Opportunistic Pathogens 1997; 9: 7-13.
22. Buchheidt D, Baust C, Skladny H, Baldus M, Brauninger S, Hehlmann R. Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients. Br J Haematol 2002; 116: 803-11.
23. Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of Aspergillus in BAL. Chest 2002; 121: 1171-6.
24. Lass-Florl C, Aigner J, Gunsilius E, Petzer A, Nachbaur D, Gastl G, et al. Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haematol 2001; 113: 180-4.
25. Raad I, Hanna H, Sumoza D, Albitar M. Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients. Cancer 2002; 94: 1032-6.
26. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive aspergillosis. Respir Med 1992; 86: 243-8.
27. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
28. Subira M, Martino R, Rovira M, Vazquez L, Serrano D, de La Camara R. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 2003; 82: 80-2.